Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Hematuria | Research

Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children

Authors: Karnchanit Sausukpaiboon, Sunee Panombualert, Suwannee Wisanuyotin, Anucha Puapairoj, Piyanan Suparattanagool, Leelawadee Techasatian, Nattakarn Tantawarak

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

IgA nephropathy in children has various clinical manifestations. Kidney biopsy is a gold standard for diagnosis by using Oxford classification 2016 with few studies about the correlation between clinical and pathology manifestations. This study aims to find these correlations at the time of diagnosis and during short-term follow-up.

Method

In this retrospective cohort study, 47 pediatric patients who underwent renal biopsy from 2010 to 2021 in Thailand, were included. Oxford classification 2016 has been used to score patients’ pathology. Univariate and multivariate associations have been used for correlation between clinical and pathologic parameters.

Results

The most common clinical manifestations were microscopic hematuria and proteinuria. There were 68% of children with mesangial hypercellularity (M1), 42% with segmental glomerulosclerosis (S1), 25% with moderate to severe crescent (C1/C2), 23% with endocapillary hypercellularity (E1), and 14% with moderate to a severe tubular atrophy/interstitial fibrosis (T1/T2). Microscopic hematuria was strongly associated with mesangial hypercellularity (M1) OR 7.14 (95%CI 1.83 – 27.88, p-value 0.005) and hypertension was strongly associated with segmental glomerulosclerosis (S1) adjusted OR 7.87 (95%CI 1.65 – 37.59, p-value 0.01). Intensive treatment was used more in the patients with tubular atrophy/interstitial fibrosis lesion on renal biopsy than other lesions from MEST-C scores OR 4.98 (95%CI 1.17–21.24, p-value 0.03). Furthermore, pulse methylprednisolone and cyclophosphamide were used in patients with crescentic lesions significantly than other lesions with OR 15.5 (95%CI 3.16- 75.93, p-value 0.001) and OR 5.75 (95%CI 1.31–25.29, p-value 0.021), respectively.

Conclusion

Tubular atrophy/interstitial fibrosis and crescent lesions were correlated to intensive treatment in short-term outcomes.
Literature
1.
go back to reference Li L-S, Liu Z-H. Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int. 2004;66:920–3.CrossRefPubMed Li L-S, Liu Z-H. Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int. 2004;66:920–3.CrossRefPubMed
2.
go back to reference Das U, Dakshinamurty K, Prayaga A, Uppin M. Spectrum of IgA nephropathy in a single center. Saudi J Kidney Dis Transplant. 2015;26:1057.CrossRef Das U, Dakshinamurty K, Prayaga A, Uppin M. Spectrum of IgA nephropathy in a single center. Saudi J Kidney Dis Transplant. 2015;26:1057.CrossRef
3.
go back to reference Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91:1014–21.CrossRefPubMed Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91:1014–21.CrossRefPubMed
4.
go back to reference Le W, Zeng C-H, Liu Z, Liu D, Yang Q, Lin R-X, et al. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol. 2012;13:158.CrossRefPubMedPubMedCentral Le W, Zeng C-H, Liu Z, Liu D, Yang Q, Lin R-X, et al. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol. 2012;13:158.CrossRefPubMedPubMedCentral
5.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1–138. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1–138.
6.
go back to reference Kitajima T, Murakami M, Sakai O. Clinicopathological features in the Japanese patients with IgA nephropathy. Jpn J Med. 1983;22:219–22.CrossRefPubMed Kitajima T, Murakami M, Sakai O. Clinicopathological features in the Japanese patients with IgA nephropathy. Jpn J Med. 1983;22:219–22.CrossRefPubMed
7.
go back to reference Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86:828–36.CrossRefPubMedPubMedCentral Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86:828–36.CrossRefPubMedPubMedCentral
8.
go back to reference Cambier A, Gleeson PJ, Flament H, Le Stang M-B, Monteiro RC. New therapeutic perspectives for IgA nephropathy in children. Pediatr Nephrol. 2021;36:497–506.CrossRefPubMed Cambier A, Gleeson PJ, Flament H, Le Stang M-B, Monteiro RC. New therapeutic perspectives for IgA nephropathy in children. Pediatr Nephrol. 2021;36:497–506.CrossRefPubMed
9.
go back to reference Kwak N, Park MJ, Jang HM, Baek HS, Lee SI, Han MH, et al. Clinical outcomes in pediatric patients with normal renal histopathology. Kidney Res Clin Pract. 2022;41:58–65.CrossRefPubMed Kwak N, Park MJ, Jang HM, Baek HS, Lee SI, Han MH, et al. Clinical outcomes in pediatric patients with normal renal histopathology. Kidney Res Clin Pract. 2022;41:58–65.CrossRefPubMed
11.
go back to reference Barbour SJ, Coppo R, Er L, Russo ML, Liu Z-H, Ding J, et al. Updating the International IgA Nephropathy Prediction Tool for use in children. Kidney Int. 2021;99:1439–50.CrossRefPubMed Barbour SJ, Coppo R, Er L, Russo ML, Liu Z-H, Ding J, et al. Updating the International IgA Nephropathy Prediction Tool for use in children. Kidney Int. 2021;99:1439–50.CrossRefPubMed
12.
go back to reference Edstrom Halling S, Soderberg MP, Berg UB. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dial Transplant. 2012;27:715–22.CrossRefPubMed Edstrom Halling S, Soderberg MP, Berg UB. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dial Transplant. 2012;27:715–22.CrossRefPubMed
13.
go back to reference A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts ISD, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.CrossRef A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts ISD, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.CrossRef
14.
go back to reference Wu H, Xia Z, Gao C, Zhang P, Yang X, Wang R, et al. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study. BMC Nephrol. 2020;21:247.CrossRefPubMedPubMedCentral Wu H, Xia Z, Gao C, Zhang P, Yang X, Wang R, et al. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study. BMC Nephrol. 2020;21:247.CrossRefPubMedPubMedCentral
15.
go back to reference Coppo R. Biomarkers and targeted new therapies for IgA nephropathy. Pediatr Nephrol. 2017;32:725–31.CrossRefPubMed Coppo R. Biomarkers and targeted new therapies for IgA nephropathy. Pediatr Nephrol. 2017;32:725–31.CrossRefPubMed
16.
go back to reference Coppo R. Treatment of IgA nephropathy in children: a land without KDIGO guidance. Pediatr Nephrol. 2021;36:491–6.CrossRefPubMed Coppo R. Treatment of IgA nephropathy in children: a land without KDIGO guidance. Pediatr Nephrol. 2021;36:491–6.CrossRefPubMed
Metadata
Title
Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children
Authors
Karnchanit Sausukpaiboon
Sunee Panombualert
Suwannee Wisanuyotin
Anucha Puapairoj
Piyanan Suparattanagool
Leelawadee Techasatian
Nattakarn Tantawarak
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-03002-3

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue